Wegovy Cut Heart Attack, Stroke Risks by 20%, Study Finds
A Novo Nordisk study claims its Wegovy weight loss drug can reduce the risk of heart attacks, strokes and cardiovascular death by 20%.
A Novo Nordisk study claims its Wegovy weight loss drug can reduce the risk of heart attacks, strokes and cardiovascular death by 20%.
The FDA has approved a weight loss version of Eli Lilly's diabetes drug, Mounjaro, which will be marketed under the name Zepbound.